SJS Fact Sheet - Stevens Johnson Syndrome Foundation
... death in the United States. Yet, less than one percent are reported to the FDA, because there is no mandatory reporting system in effect for postmarketing adverse drug reactions. Similarly, no one has an accurate count of the cases of SJS and TENS. Although SJS is listed as a rare disease, it may be ...
... death in the United States. Yet, less than one percent are reported to the FDA, because there is no mandatory reporting system in effect for postmarketing adverse drug reactions. Similarly, no one has an accurate count of the cases of SJS and TENS. Although SJS is listed as a rare disease, it may be ...
Clinical characteristics of childhood erythema multiforme, Stevens
... to the medication [1,5]. Rzany et al had suggested that SJS and TEN are associated with short-term therapy with phenytoin, phenobarbital, and carbamazepine [10]. Lamotrigine has the potential for inducing severe skin reaction. In our study, the onset of drug-related reaction was typically 2 weeks af ...
... to the medication [1,5]. Rzany et al had suggested that SJS and TEN are associated with short-term therapy with phenytoin, phenobarbital, and carbamazepine [10]. Lamotrigine has the potential for inducing severe skin reaction. In our study, the onset of drug-related reaction was typically 2 weeks af ...
Prednisone - Therapeutic Goods Administration (TGA)
... immediately after a full evening meal (C). * Decortin is available in Germany (not available in Australia). ...
... immediately after a full evening meal (C). * Decortin is available in Germany (not available in Australia). ...
article in press - UBC Critical Care Medicine, Vancouver BC
... patients with secondary HTN comprise only a small percentage of those with elevated BP, this subgroup should not be ignored. To this date, no consensus has been established as a parameter for the evaluation and treatment of secondary HTN. Among the large number of people with HTN, it is helpful to k ...
... patients with secondary HTN comprise only a small percentage of those with elevated BP, this subgroup should not be ignored. To this date, no consensus has been established as a parameter for the evaluation and treatment of secondary HTN. Among the large number of people with HTN, it is helpful to k ...
Drug induced exfoliative dermatitis: state of the art | SpringerLink
... of roughly 5–12.5 % for SJS and 50 % for TEN [1, 2]. In general, they occur more frequently in women, with a male to female ratio of 0.6 [22]. The overall mortality rate is roughly 30 %, ranging from 10 % for SJS to more than 30 % for TEN, with the survival rate worsening until 1 year after disease ...
... of roughly 5–12.5 % for SJS and 50 % for TEN [1, 2]. In general, they occur more frequently in women, with a male to female ratio of 0.6 [22]. The overall mortality rate is roughly 30 %, ranging from 10 % for SJS to more than 30 % for TEN, with the survival rate worsening until 1 year after disease ...
The Road to Rehabilitation, Part 7
... with the other treatments discussed. The effects of injections will vary with dosing, muscle selection and administration of other interventions. Botulinum Toxin A (Botox®) is derived from the bacteria causing botulism. Injected in small doses into the affected muscle, it weakens the muscle by block ...
... with the other treatments discussed. The effects of injections will vary with dosing, muscle selection and administration of other interventions. Botulinum Toxin A (Botox®) is derived from the bacteria causing botulism. Injected in small doses into the affected muscle, it weakens the muscle by block ...
Product Monograph Template - Standard
... anaphylaxis attributed to XOLAIR® use was estimated to be at least 0.2% of patients based on an estimated exposure of about 57,300 patients from June 2003 through December 2006. Anaphylaxis and anaphylactoid reactions have been reported following the first or subsequent administrations of XOLAIR®. A ...
... anaphylaxis attributed to XOLAIR® use was estimated to be at least 0.2% of patients based on an estimated exposure of about 57,300 patients from June 2003 through December 2006. Anaphylaxis and anaphylactoid reactions have been reported following the first or subsequent administrations of XOLAIR®. A ...
HER2-positive Metastatic Breast Cancer: New Agents on the Horizon
... In patients who progress after first-line therapy with trastuzumab plus chemotherapy, the combination of lapatinib and capecitabine has been shown to improve time to progression (TTP) compared to capecitabine alone (median TTP, 8.4 vs. 4.4 months), although this did not translate into a significant ...
... In patients who progress after first-line therapy with trastuzumab plus chemotherapy, the combination of lapatinib and capecitabine has been shown to improve time to progression (TTP) compared to capecitabine alone (median TTP, 8.4 vs. 4.4 months), although this did not translate into a significant ...
Acute Oncology Guidelines (2014) Version 2.0
... serotonin. This effect is thought to be most marked on peripheral as opposed to central receptors. There are a number of first generation 5HT 3 serotonin receptor antagonists available including ondansetron, granisetron, and dolesetron. When used in appropriate doses these three drugs appear to be e ...
... serotonin. This effect is thought to be most marked on peripheral as opposed to central receptors. There are a number of first generation 5HT 3 serotonin receptor antagonists available including ondansetron, granisetron, and dolesetron. When used in appropriate doses these three drugs appear to be e ...
Bipolar Disorder
... mixed mania, or a mixed state, in which both mania and depression coexist. Rapid Cycling. About 15% of patients with the disorder have a temporary, complicated phase known as rapid cycling. With this phase the manic and depressive episodes alternate at least four times a year and, in severe cases, c ...
... mixed mania, or a mixed state, in which both mania and depression coexist. Rapid Cycling. About 15% of patients with the disorder have a temporary, complicated phase known as rapid cycling. With this phase the manic and depressive episodes alternate at least four times a year and, in severe cases, c ...
ecstasy - California State University
... to high doses of MDMA for 4 days produced brain damage that could still be seen 6 to 7 years later. ...
... to high doses of MDMA for 4 days produced brain damage that could still be seen 6 to 7 years later. ...
Hepatic Encephalopathy in Chronic Liver Disease: 2014
... numbers indicate that OHE will occur in 30%–40% of those with cirrhosis at some time during their clinical course and in the survivors in most cases repeatedly [22]. Minimal HE (MHE) or covert HE (CHE) occurs in 20%–80% of patients with cirrhosis [23–27,81]. The prevalence of HE in prehepatic noncir ...
... numbers indicate that OHE will occur in 30%–40% of those with cirrhosis at some time during their clinical course and in the survivors in most cases repeatedly [22]. Minimal HE (MHE) or covert HE (CHE) occurs in 20%–80% of patients with cirrhosis [23–27,81]. The prevalence of HE in prehepatic noncir ...
SUMMARY OF PRODUCT CHARACTERISTICS NAME OF THE
... Cases of hepatic venoocclusive disease (sinusoidal obstruction syndrome) have been reported, some of which were fatal. Patients should be monitored for signs and symptoms of abnormal liver function or portal hypertension which do not obviously result from liver metastases. Tumour lysis syndrome (TLS ...
... Cases of hepatic venoocclusive disease (sinusoidal obstruction syndrome) have been reported, some of which were fatal. Patients should be monitored for signs and symptoms of abnormal liver function or portal hypertension which do not obviously result from liver metastases. Tumour lysis syndrome (TLS ...
Clinical Thyroidology March 2001 Volume 13 Issue 1
... concentrations in the six months before they were studied and the study included use of the Short Form 36 to assess well being. The overall findings are similar to those found in patients with subclinical hyperthyroidism caused by exogenous thyroxine (T4) therapy by the same investigators (1); the S ...
... concentrations in the six months before they were studied and the study included use of the Short Form 36 to assess well being. The overall findings are similar to those found in patients with subclinical hyperthyroidism caused by exogenous thyroxine (T4) therapy by the same investigators (1); the S ...
Prostatitis What is prostatitis?
... nonbacterial prostatitis. This is because of the difficulties in obtaining a specimen and, sometimes, previous antibiotic therapy obscures the diagnosis. An organism that responds to antibiotics, but is difficult to diagnose may also cause chronic pelvic pain syndrome. For these reasons, antibiot ...
... nonbacterial prostatitis. This is because of the difficulties in obtaining a specimen and, sometimes, previous antibiotic therapy obscures the diagnosis. An organism that responds to antibiotics, but is difficult to diagnose may also cause chronic pelvic pain syndrome. For these reasons, antibiot ...
January/March 2013 1 Volume 19
... FLASH). The thickness of the layer was 5 mm. Due to the fact that sequences with short acquisition time that limit fetal movement were used, sedation of the patients was not necessary. All examinations took an average of 37 minutes. RESULTS In this study, eleven fetuses suspected of various organ ma ...
... FLASH). The thickness of the layer was 5 mm. Due to the fact that sequences with short acquisition time that limit fetal movement were used, sedation of the patients was not necessary. All examinations took an average of 37 minutes. RESULTS In this study, eleven fetuses suspected of various organ ma ...
Best Practices for Intrathecal Drug Delivery for Pain
... therapy. Comorbidities such as obstructive sleep apnea, diabetes, obesity, metabolic syndrome, or chronic lung, cardiac, or kidney disease or smoking increase the risk of complications (13). Patients should also know that achieving an appropriate balance between pain management and side effects takes ...
... therapy. Comorbidities such as obstructive sleep apnea, diabetes, obesity, metabolic syndrome, or chronic lung, cardiac, or kidney disease or smoking increase the risk of complications (13). Patients should also know that achieving an appropriate balance between pain management and side effects takes ...
Treatment of Cutaneous Leishmaniasis Caused by
... and can cause severe and complicated cases such as diffuse CL (DCL), mucocutaneous leishmaniasis or extensive CL, requiring systemic treatment. Despite the substantial burden, evidence-based treatment guidelines are lacking. We conducted a systematic review of clinical studies reporting on treatment ...
... and can cause severe and complicated cases such as diffuse CL (DCL), mucocutaneous leishmaniasis or extensive CL, requiring systemic treatment. Despite the substantial burden, evidence-based treatment guidelines are lacking. We conducted a systematic review of clinical studies reporting on treatment ...
Bez tytułu slajdu
... Immune mediated effects are inherent in their activity, but hypersensitivities are rare and mainly due to immunoglobulins (IgE, IgG) ...
... Immune mediated effects are inherent in their activity, but hypersensitivities are rare and mainly due to immunoglobulins (IgE, IgG) ...
Minimally Invasive Treatment Options for Uterine Fibroids
... from UAE. Spies et al [15] published a series of 200 consecutive patients followed after UAE for 5 years. At the end of 5 years, 73% reported continued symptom relief, 18% had undergone hysterectomy or myomectomy, and 2% had a repeat UAE. Long-term failure was greatest for women with larger baseline ...
... from UAE. Spies et al [15] published a series of 200 consecutive patients followed after UAE for 5 years. At the end of 5 years, 73% reported continued symptom relief, 18% had undergone hysterectomy or myomectomy, and 2% had a repeat UAE. Long-term failure was greatest for women with larger baseline ...
PRACTICE GUIDELINES
... 1. A presumptive diagnosis of GERD can be established in the setting of typical symptoms of heartburn and regurgitation. Empiric medical therapy with a proton pump inhibitor (PPI) is recommended in this setting. (Strong recommendation, moderate level of evidence) 2. Patients with non-cardiac chest p ...
... 1. A presumptive diagnosis of GERD can be established in the setting of typical symptoms of heartburn and regurgitation. Empiric medical therapy with a proton pump inhibitor (PPI) is recommended in this setting. (Strong recommendation, moderate level of evidence) 2. Patients with non-cardiac chest p ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.